课题基金 / 基金详情

2/2 Targeted Sequencing and Functional Evaluation of Mutations in Schizophrenia

2/2 Targeted Sequencing and Functional Evaluation of Mutations in Schizophrenia
2/2 精神分裂症突变的靶向测序和功能评估
批准号:
9069531
负责人:
Pablo V. Gejman
金额:
$34.89万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2018-02-28

项目摘要

项目成果

Pablo V. Gejman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Schizophrenia (SZ) is a severe psychiatric disorder that affects 1% of the population worldwide and has a strong genetic influence on susceptibility. Recent genetic investigations of SZ, such as genome-wide association studies (GWAS) and structural genomic studies have made remarkable progress but leave a substantial part of the genetic risk unexplained, suggesting alternative models should be explored. We have designed a targeted sequencing experiment, by selecting coding and regulatory sequence in genomic intervals with high prior evidence for involvement in SZ. Our targets come from (i) genes that reside within SZ- associated copy number variant (CNV) intervals, or (ii) genes that show extreme transcriptional departures in SZ, for a total of ~600kb of sequence. We propose sequencing sample from the Molecular Genetics of SZ (MGS) collection and extracting sequence from the Genomic Psychiatry Cohort (GPC), resulting in a large, combined European ancestry (EA) discovery sample of 3,181 SZ cases and 3,500 matched controls. By limiting our target to a region that is small but likely enriched for SZ associated low frequency variants, we both lower the statistical threshold required for significance, and economically allow for a large sample size, giving us maximal power to identify new associations for SZ. We will then examine top hits for replication in the remaining GPC EA sample of 4,100 SZ cases and screened 5,400 controls. In addition, we propose adding another dimension of information, by functional evaluation of our most promising candidates. To accomplish this goal, in subsequent initial, exploratory work, we will generate and phenotypically characterize induced pluripotent stem cell (iPSC)-differentiated neurons from patients harboring associated mutations and from controls. If successful, our study will identify genes, putative mutations, and a mechanism of action by which those mutations contribute to SZ pathology. In this way we expect to refine our understanding of SZ and advance new, focused hypotheses to be tested. All data and biological materials will be rapidly shared through the designated NIMH repository (www.nimhgenetics.org) and dbGaP (dbgap.ncbi.nlm.nih.gov).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2/2 Targeted Sequencing and Functional Evaluation of Mutations in Schizophrenia
1/2 An Integrative Genetic Investigation of Schizophrenia
1/2 An Integrative Genetic Investigation of Schizophrenia
1/2 An Integrative Genetic Investigation of Schizophrenia
国内基金
海外基金
伴1q21扩增MM细胞IFI16过表达通过刺激TAM增殖及活化促进自身发生发展的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    李晓哲
  • 依托单位:
新抑癌基因表观调控高危多发性骨髓瘤1q21区基因表达的多组学和机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    戴云
  • 依托单位:
RNA m6A阅读器IGF2BP3通过CKS1B mRNA促进伴有染色体1q21扩增的多发性骨髓瘤细胞增殖的机制研究
  • 批准号:
    82100215
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    徐佳岱
  • 依托单位:
染色体1q21在多发性骨髓瘤疾病进展中的机制及其上关键基因的研究
  • 批准号:
    30800484
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2008
  • 负责人:
    张艳
  • 依托单位: